Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Vaccines

  Free Subscription


19.08.2019

1 Arch Virol
5 Clin Infect Dis
2 J Immunol
4 J Infect Dis
1 J Virol
3 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
1 Pediatr Infect Dis J
3 PLoS One
1 Proc Natl Acad Sci U S A
16 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. PONDE RAA
    Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity.
    Arch Virol. 2019 Aug 9. pii: 10.1007/s00705-019-04369.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  2. WEINBERGER DM, Shapiro ED
    Pneumococcal Vaccines for Adults: What's Next?
    Clin Infect Dis. 2019 Aug 12. pii: 5546063. doi: 10.1093.
    PubMed     Text format    

  3. GOUMA S, Weirick M, Hensley SE
    Potential antigenic mismatch of the H3N2 component of the 2019 Southern Hemisphere influenza vaccine.
    Clin Infect Dis. 2019 Aug 11. pii: 5546015. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. LINDSEY BB, Hoschler K, de Silva TI
    Complexities in predicting the immunogenicity of live attenuated influenza vaccines.
    Clin Infect Dis. 2019 Aug 14. pii: 5549953. doi: 10.1093.
    PubMed     Text format    

  5. MONTO AS
    Effectiveness of the live attenuated influenza vaccine: was additional of the second type B lineage a step too far?
    Clin Infect Dis. 2019 Aug 13. pii: 5549602. doi: 10.1093.
    PubMed     Text format    

  6. AHMED SS, Pondo T, Xing W, McGee L, et al
    Early Impact of 13-valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease among Adults with and without Underlying Medical Conditions-United States.
    Clin Infect Dis. 2019 Aug 12. pii: 5546062. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Immunol

  7. MAGADAN S, Jouneau L, Boudinot P, Salinas I, et al
    Nasal Vaccination Drives Modifications of Nasal and Systemic Antibody Repertoires in Rainbow Trout.
    J Immunol. 2019 Aug 14. pii: jimmunol.1900157. doi: 10.4049/jimmunol.1900157.
    PubMed     Text format     Abstract available

  8. DIPIAZZA AT, Fan S, Rattan A, DeDiego ML, et al
    A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal Influenza.
    J Immunol. 2019 Aug 9. pii: jimmunol.1900819. doi: 10.4049/jimmunol.1900819.
    PubMed     Text format     Abstract available


    J Infect Dis

  9. MUNOZ FM, Swamy GK, Hickman SP, Agrawal S, et al
    Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
    J Infect Dis. 2019 Aug 12. pii: 5546089. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. CHOI YH, Perez-Cuevas MB, Kodani M, Zhang X, et al
    Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques.
    J Infect Dis. 2019 Aug 13. pii: 5549399. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. GODI A, Kemp TJ, Pinto LA, Beddows S, et al
    Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies.
    J Infect Dis. 2019 Aug 15. pii: 5550116. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. SALPINI R, Pietrobattista A, Piermatteo L, Basso MS, et al
    Establishment of a seronegative occult infection with an active HBV reservoir enriched of vaccine escape mutations in a vaccinated infant after liver transplant.
    J Infect Dis. 2019 Aug 14. pii: 5550108. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  13. ALMOND N, Berry N, Stebbings R, Preston M, et al
    Vaccination of macaques with DNA followed by adenoviral vectors encoding SIV gag alone delays infection by repeated mucosal challenge with SIV.
    J Virol. 2019 Aug 14. pii: JVI.00606-19. doi: 10.1128/JVI.00606.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  14. LJUNGMAN P
    Varicella zoster virus vaccine in patients with haematological malignancies.
    Lancet Infect Dis. 2019 Aug 6. pii: S1473-3099(19)30400.
    PubMed     Text format    

  15. DAGNEW AF, Ilhan O, Lee WS, Woszczyk D, et al
    Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.
    Lancet Infect Dis. 2019 Aug 6. pii: S1473-3099(19)30163.
    PubMed     Text format     Abstract available

  16. MULLANE KM, Morrison VA, Camacho LH, Arvin A, et al
    Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial.
    Lancet Infect Dis. 2019 Aug 6. pii: S1473-3099(19)30310.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  17. MEITES E, Szilagyi PG, Chesson HW, Unger ER, et al
    Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.
    MMWR Morb Mortal Wkly Rep. 2019;68:698-702.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  18. JAYASINGHE S, Liu B, Gidding H, Gibson A, et al
    Long-term Vaccine Impact on Invasive Pneumococcal Disease Among Children With Significant Comorbidities in a Large Australian Birth Cohort.
    Pediatr Infect Dis J. 2019;38:967-973.
    PubMed     Text format     Abstract available


    PLoS One

  19. WOLFSON LJ, Daniels VJ, Pillsbury M, Kurugol Z, et al
    Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model.
    PLoS One. 2019;14:e0220921.
    PubMed     Text format     Abstract available

  20. JEONG S, Jang EJ, Jo J, Jang S, et al
    Effects of maternal influenza vaccination on adverse birth outcomes: A systematic review and Bayesian meta-analysis.
    PLoS One. 2019;14:e0220910.
    PubMed     Text format     Abstract available

  21. CAMPBELL ZA, Thumbi SM, Marsh TL, Quinlan MB, et al
    Why isn't everyone using the thermotolerant vaccine? Preferences for Newcastle disease vaccines by chicken-owning households in Tanzania.
    PLoS One. 2019;14:e0220963.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  22. DE LIMA DS, Cardozo LE, Maracaja-Coutinho V, Suhrbier A, et al
    Long noncoding RNAs are involved in multiple immunological pathways in response to vaccination.
    Proc Natl Acad Sci U S A. 2019 Aug 9. pii: 1822046116.
    PubMed     Text format     Abstract available


    Vaccine

  23. SOUSA M, Fenge C, Rupprecht J, Tappe A, et al
    Process intensification for Peste des Petites Ruminants Virus vaccine production.
    Vaccine. 2019 Aug 8. pii: S0264-410X(19)30887.
    PubMed     Text format     Abstract available

  24. PATON DJ, Reeve R, Capozzo AV, Ludi A, et al
    Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory.
    Vaccine. 2019 Aug 9. pii: S0264-410X(19)31023.
    PubMed     Text format     Abstract available

  25. THYSEN SM, Byberg S, Martins JSD, Kallestrup P, et al
    Household costs of seeking BCG vaccination in rural Guinea-Bissau.
    Vaccine. 2019 Aug 9. pii: S0264-410X(19)31041.
    PubMed     Text format     Abstract available

  26. WORLD HEALTH ORGANIZATION
    Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations.
    Vaccine. 2017 Jul 22. pii: S0264-410X(17)30954.
    PubMed     Text format     Abstract available

  27. WORLD HEALTH ORGANIZATION
    Measles vaccines: WHO position paper, April 2017 - Recommendations.
    Vaccine. 2019;37:219-222.
    PubMed     Text format     Abstract available

  28. PANOZZO CA, Pourmalek F, Brauchli Pernus Y, Pileggi GS, et al
    Arthritis and arthralgia as an adverse event following immunization: A systematic literature review.
    Vaccine. 2019;37:372-383.
    PubMed     Text format     Abstract available

  29. NAILI I, Vinot J, Baudner BC, Bernalier-Donadille A, et al
    Mixed mucosal-parenteral immunizations with the broadly conserved pathogenic Escherichia coli antigen SslE induce a robust mucosal and systemic immunity without affecting the murine intestinal microbiota.
    Vaccine. 2019;37:314-324.
    PubMed     Text format     Abstract available

  30. ZHAO F, Zhai Y, Zhu J, Xiao P, et al
    Enhancement of autophagy as a strategy for development of new DNA vaccine candidates against Japanese encephalitis.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31014.
    PubMed     Text format     Abstract available

  31. GEBAUER M, Hurlimann HC, Behrens M, Wolff T, et al
    Subunit vaccines based on recombinant yeast protect against influenza A virus in a one-shot vaccination scheme.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31015.
    PubMed     Text format     Abstract available

  32. HUNG MC, Cho CY, Chen CJ, Lai CC, et al
    Immunogenicity and safety of an inactivated enterovirus A71 vaccine in children 3-6years and 2-35months of age- an open-label, randomized phase IIb clinical trial.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31017.
    PubMed     Text format     Abstract available

  33. SOUZA IEL, Fernandes FF, Schiavoni MCL, Silva CL, et al
    Therapeutic effect of DNA vaccine encoding the 60-kDa-heat shock protein from Paracoccidoides brasiliensis on experimental paracoccidioidomycosis in mice.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31011.
    PubMed     Text format     Abstract available

  34. ASTHAGIRI ARUNKUMAR G, McMahon M, Pavot V, Aramouni M, et al
    Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31016.
    PubMed     Text format     Abstract available

  35. OZAWA S, Yemeke TT, Evans DR, Pallas SE, et al
    Defining hard-to-reach populations for vaccination.
    Vaccine. 2019 Aug 7. pii: S0264-410X(19)30858.
    PubMed     Text format     Abstract available

  36. GUO A, Lindley MC, Hurley LP, Allen JA, et al
    Ten years of experience with herpes zoster vaccine in primary care- how attitudes and practices have changed and what it may mean for a new zoster vaccine.
    Vaccine. 2019 Aug 7. pii: S0264-410X(19)31027.
    PubMed     Text format     Abstract available

  37. MACINTYRE CR, Shaw PJ, Mackie FE, Boros C, et al
    Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children.
    Vaccine. 2019 Aug 8. pii: S0264-410X(19)30993.
    PubMed     Text format     Abstract available

  38. PANDA S, Chatterjee P, Deb A, Kanungo S, et al
    Preventing cholera in India: Synthesizing evidences through a systematic review for policy discussion on the use of oral cholera vaccine.
    Vaccine. 2019 Aug 9. pii: S0264-410X(19)30920.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: